162 related articles for article (PubMed ID: 35581650)
1. Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis.
Vesga JF; Lienhardt C; Nsengiyumva P; Campbell JR; Oxlade O; den Boon S; Falzon D; Schwartzman K; Churchyard G; Arinaminpathy N
BMC Med; 2022 May; 20(1):182. PubMed ID: 35581650
[TBL] [Abstract][Full Text] [Related]
2. Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model.
Kendall EA; Shrestha S; Cohen T; Nuermberger E; Dooley KE; Gonzalez-Angulo L; Churchyard GJ; Nahid P; Rich ML; Bansbach C; Forissier T; Lienhardt C; Dowdy DW
PLoS Med; 2017 Jan; 14(1):e1002202. PubMed ID: 28045934
[TBL] [Abstract][Full Text] [Related]
3. Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis.
Ryckman TS; Schumacher SG; Lienhardt C; Sweeney S; Dowdy DW; Mirzayev F; Kendall EA
Lancet Glob Health; 2024 Jun; 12(6):e995-e1004. PubMed ID: 38762299
[TBL] [Abstract][Full Text] [Related]
4. Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
Nsengiyumva NP; Campbell JR; Oxlade O; Vesga JF; Lienhardt C; Trajman A; Falzon D; Den Boon S; Arinaminpathy N; Schwartzman K
PLoS Med; 2022 Jun; 19(6):e1004032. PubMed ID: 35696431
[TBL] [Abstract][Full Text] [Related]
5. Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations.
Kendall EA; Malhotra S; Cook-Scalise S; Denkinger CM; Dowdy DW
BMC Infect Dis; 2019 Sep; 19(1):794. PubMed ID: 31500572
[TBL] [Abstract][Full Text] [Related]
6. The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis.
Arinaminpathy N; Gomez GB; Sachdeva KS; Rao R; Parmar M; Nair SA; Rade K; Kumta S; Hermann D; Hanson C; Chin DP; Dewan P
PLoS One; 2020; 15(3):e0230808. PubMed ID: 32218585
[TBL] [Abstract][Full Text] [Related]
7. The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach.
Mandal S; Bhatia V; Sharma M; Mandal PP; Arinaminpathy N
BMC Med; 2020 Jul; 18(1):163. PubMed ID: 32684164
[TBL] [Abstract][Full Text] [Related]
8. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.
Grace AG; Mittal A; Jain S; Tripathy JP; Satyanarayana S; Tharyan P; Kirubakaran R
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012918. PubMed ID: 31828771
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.
Houben RMGJ; Menzies NA; Sumner T; Huynh GH; Arinaminpathy N; Goldhaber-Fiebert JD; Lin HH; Wu CY; Mandal S; Pandey S; Suen SC; Bendavid E; Azman AS; Dowdy DW; Bacaër N; Rhines AS; Feldman MW; Handel A; Whalen CC; Chang ST; Wagner BG; Eckhoff PA; Trauer JM; Denholm JT; McBryde ES; Cohen T; Salomon JA; Pretorius C; Lalli M; Eaton JW; Boccia D; Hosseini M; Gomez GB; Sahu S; Daniels C; Ditiu L; Chin DP; Wang L; Chadha VK; Rade K; Dewan P; Hippner P; Charalambous S; Grant AD; Churchyard G; Pillay Y; Mametja LD; Kimerling ME; Vassall A; White RG
Lancet Glob Health; 2016 Nov; 4(11):e806-e815. PubMed ID: 27720688
[TBL] [Abstract][Full Text] [Related]
10. WHO target product profiles for TB preventive treatment.
Den Boon S; Lienhardt C; Zignol M; Schwartzman K; Arinaminpathy N; Campbell JR; Nahid P; Penazzato M; Menzies D; Vesga JF; Oxlade O; Churchyard G; Merle CS; Kasaeva T; Falzon D
Int J Tuberc Lung Dis; 2022 Apr; 26(4):302-309. PubMed ID: 35351234
[TBL] [Abstract][Full Text] [Related]
11. The predicted impact of tuberculosis preventive therapy: the importance of disease progression assumptions.
Sumner T; White RG
BMC Infect Dis; 2020 Nov; 20(1):880. PubMed ID: 33228580
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
Yanes-Lane M; Ortiz-Brizuela E; Campbell JR; Benedetti A; Churchyard G; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003738. PubMed ID: 34520459
[TBL] [Abstract][Full Text] [Related]
13. Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.
Fofana MO; Knight GM; Gomez GB; White RG; Dowdy DW
PLoS One; 2014; 9(5):e96389. PubMed ID: 24816692
[TBL] [Abstract][Full Text] [Related]
14. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
[TBL] [Abstract][Full Text] [Related]
15. Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessment.
Dorjee K; Topgyal S; Tsewang T; Tsundue T; Namdon T; Bonomo E; Kensler C; Lhadon D; Choetso T; Nangsel T; Dolkar T; Tsekyi T; Dorjee C; Phunkyi D; Sadutshang TD; Paster Z; Chaisson RE
PLoS Med; 2021 Jan; 18(1):e1003502. PubMed ID: 33465063
[TBL] [Abstract][Full Text] [Related]
16. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
[TBL] [Abstract][Full Text] [Related]
17. Six-month therapy for abdominal tuberculosis.
Jullien S; Jain S; Ryan H; Ahuja V
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012163. PubMed ID: 27801499
[TBL] [Abstract][Full Text] [Related]
18. Prospects for advancing tuberculosis control efforts through novel therapies.
Salomon JA; Lloyd-Smith JO; Getz WM; Resch S; Sánchez MS; Porco TC; Borgdorff MW
PLoS Med; 2006 Aug; 3(8):e273. PubMed ID: 16866578
[TBL] [Abstract][Full Text] [Related]
19. Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru.
Yuen CM; Millones AK; Galea JT; Puma D; Jimenez J; Lecca L; Becerra MC; Keshavjee S
BMC Public Health; 2021 Jan; 21(1):121. PubMed ID: 33430823
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
